Liu Jing, Gao Xiang, Chen Ye, Mei Qiao, Zhu Liangru, Qian Jiaming, Hu Pinjin, Cao Qian
Inflammatory Bowel Disease Center, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Department of Internal Medicine, Peking Union Medical College Hospital, Beijing, China.
Intest Res. 2021 Jul;19(3):313-322. doi: 10.5217/ir.2020.00017. Epub 2020 Nov 25.
BACKGROUND/AIMS: Risk of venous thrombosis is increased in patients with inflammatory bowel disease (IBD); data on Asian IBD patients is limited and status quo of thrombosis screening and prophylaxis are unknown. Therefore, we aimed to investigate the incidence, screening, prophylaxis, and risk factors for venous thrombosis among Asian IBD patients.
Medical files of patients with Crohn's disease (CD) and ulcerative colitis (UC) from 17 hospitals across China between 2011 and 2016 were reviewed for venous thrombosis, use of screening and prophylaxis. A case-control study was performed among hospitalized patients with venous thrombosis and their age-, sex-matched IBD controls hospitalized around the same period; disease characteristics and known provoking factors of venous thrombosis were recorded. Risk factors were analyzed in both univariate and logistic regression analyses.
A total of 8,459 IBD patients were followed for 12,373 person-year. Forty-six patients (0.54%) had venous thrombosis, yielding an incidence of 37.18 per 10,000 person-year. Incidence increased with age, especially among CD. Less than 20% of patients received screening tests and 35 patients (0.41%) received prophylaxis. Severe disease flare was an independent risk factor for venous thrombosis (odds ratio [95% confidence interval]: CD, 9.342 [1.813- 48.137]; UC, 5.198 [1.268-21.305]); past use of steroids and extensive involvement were 2 additional risk factors in CD and UC, respectively.
Incidence of venous thrombosis in China was 37.18 per 10,000 person-year (0.54%). Use of screening and prophylaxis were rare. Severe disease flare was an independent risk factor for thrombosis among hospitalized patients.
背景/目的:炎症性肠病(IBD)患者发生静脉血栓形成的风险增加;亚洲IBD患者的数据有限,血栓形成筛查和预防的现状尚不清楚。因此,我们旨在调查亚洲IBD患者静脉血栓形成的发生率、筛查、预防及危险因素。
回顾了2011年至2016年期间中国17家医院的克罗恩病(CD)和溃疡性结肠炎(UC)患者的医疗档案,以了解静脉血栓形成情况、筛查和预防措施的使用情况。对住院的静脉血栓形成患者及其同期住院的年龄和性别匹配的IBD对照患者进行了病例对照研究;记录了静脉血栓形成的疾病特征和已知诱发因素。在单因素和逻辑回归分析中对危险因素进行了分析。
共对8459例IBD患者进行了12373人年的随访。46例患者(0.54%)发生静脉血栓形成,发病率为每10000人年37.18例。发病率随年龄增加而升高,尤其是在CD患者中。不到20%的患者接受了筛查检查,35例患者(0.41%)接受了预防措施。严重疾病发作是静脉血栓形成的独立危险因素(比值比[95%置信区间]:CD,9.342[1.813 - 48.137];UC,5.198[1.268 - 21.305]);既往使用类固醇和广泛病变分别是CD和UC的另外两个危险因素。
中国静脉血栓形成的发病率为每10000人年37.18例(0.54%)。筛查和预防措施的使用很少。严重疾病发作是住院患者血栓形成的独立危险因素。